NO-Freisetzung durch Vitamin C, Adrenalin und Serotonin aus N-nitrosierten Tryptophan-Derivaten wie N-Nitrosomelatonin

Stickstoffmonoxid besitzt in vivo diverse Funktionen, z.B. als vasodilatative Substanz, als Neurotransmitter und ist u.a. in die Immunantwort von Makrophagen involviert. Durch seine kurze Halbwertszeit von ca. 2-3 Sekunden stellt sich die Frage nach möglichen Transport- oder Speicherformen bzw. alternativen NO-Freisetzungsmechanismen. Eine solche Quelle könnten N-nitrosierte Tryptophan-Derivate darstellen, die unter physiologischen Bedingungen NO freisetzen können. Die NO-Freisetzung aus nitrosierten Tryptophan-Derivaten wurde am Beispiel von N-Acetyl-N-nitroso-tryptophan (NANT) und N-Nitrosomelatonin (NOMela) durch physiologische Substanzen mit aktivierten Hydroxylgruppen untersucht. Als wichtige Modellsubstanzen dafür dienten Ascorbinsäure (Vitamin C), Catecholamine (Adrenalin, Dopamin) sowie Serotonin und seine Derivate. Alle erwähnten Substanzen sind in der Lage, über eine Transnitrosierungsreaktion mit nitrosierten Tryptophan-Derivaten zu reagieren. In dieser Reaktion wird das nicht-nitrosierte Tryptophan-Derivat in stöchiometrsichen Konzentrationen gebildet. Als Intermediat entsteht ein kurzlebiges O-Arylnitrit, welches homolytisch in NO und das Arylradikal zerfällt. Alternativ kann über eine Hydrolyse-Reaktion Nitrit und ein Aryl-Anion gebildet werden. Zusätzlich stellte sich heraus, dass Vitamin C eine modulierende Wirkung auf die NO-Konzentration besitzt. Ascorbinsäure kann zu einer vermehrten NO-Freisetzung führen. Die Oxidations-Produkte der Ascorbinsäure, Dehydro-Ascorbinsäure und im Verlauf das Ascorbylradikal-Anion, verringern hingegen die NO-Konzentration. Eine mögliche Anwendung dieser Reaktionen könnte im pharmakologischen Einsatz bestehen, der bereits für S-Nitrosothiole diskutiert wurde. Die beschriebenen Trans-nitrosierungsreaktionen sind jedoch für N-Nitrosotryptophane spezifisch und könnten insbesondere bei Erkrankungen mit erhöhten Catecholamin- und Serotonin-Spiegeln wie dem Phäochromozytom bzw. dem Karzinoid zu einer NO-Freisetzung mit Vasodilatation führen und gleichzeitig dem Abbau der erhöhten Hormonspiegel dienen

The Development of Neuroendocrine Disturbances over Time: Longitudinal Findings in Patients after Traumatic Brain Injury and Subarachnoid Hemorrhage

Previous reports suggest that neuroendocrine disturbances in patients with traumatic brain injury (TBI) or aneurysmal subarachnoid hemorrhage (SAH) may still develop or resolve months or even years after the trauma. We investigated a cohort of n = 168 patients (81 patients after TBI and 87 patients after SAH) in whom hormone levels had been determined at various time points to assess the course and pattern of hormonal insufficiencies. Data were analyzed using three different criteria: (1) patients with lowered basal laboratory values;(2) patients with lowered basal laboratory values or the need for hormone replacement therapy;(3) diagnosis of the treating physician. The first hormonal assessment after a median time of three months after the injury showed lowered hormone laboratory test results in 35% of cases. Lowered testosterone (23.1% of male patients), lowered estradiol (14.3% of female patients) and lowered insulin-like growth factor I (IGF-I) values (12.1%) were most common. Using Criterion 2, a higher prevalence rate of 55.6% of cases was determined, which correlated well with the prevalence rate of 54% of cases using the physicians' diagnosis as the criterion. Intraindividual changes (new onset insufficiency or recovery) were predominantly observed for the somatotropic axis (12.5%), the gonadotropic axis in women (11.1%) and the corticotropic axis (10.6%). Patients after TBI showed more often lowered IGF-I values at first testing, but normal values at follow-up (p < 0.0004). In general, most patients remained stable. Stable hormone results at follow-up were obtained in 78% (free thyroxine (fT4) values) to 94.6% (prolactin values)

The Development of Neuroendocrine Disturbances over Time: Longitudinal Findings in Patients after Traumatic Brain Injury and Subarachnoid Hemorrhage

Previous reports suggest that neuroendocrine disturbances in patients with traumatic brain injury (TBI) or aneurysmal subarachnoid hemorrhage (SAH) may still develop or resolve months or even years after the trauma. We investigated a cohort of n = 168 patients (81 patients after TBI and 87 patients after SAH) in whom hormone levels had been determined at various time points to assess the course and pattern of hormonal insufficiencies. Data were analyzed using three different criteria: (1) patients with lowered basal laboratory values;(2) patients with lowered basal laboratory values or the need for hormone replacement therapy;(3) diagnosis of the treating physician. The first hormonal assessment after a median time of three months after the injury showed lowered hormone laboratory test results in 35% of cases. Lowered testosterone (23.1% of male patients), lowered estradiol (14.3% of female patients) and lowered insulin-like growth factor I (IGF-I) values (12.1%) were most common. Using Criterion 2, a higher prevalence rate of 55.6% of cases was determined, which correlated well with the prevalence rate of 54% of cases using the physicians' diagnosis as the criterion. Intraindividual changes (new onset insufficiency or recovery) were predominantly observed for the somatotropic axis (12.5%), the gonadotropic axis in women (11.1%) and the corticotropic axis (10.6%). Patients after TBI showed more often lowered IGF-I values at first testing, but normal values at follow-up (p < 0.0004). In general, most patients remained stable. Stable hormone results at follow-up were obtained in 78% (free thyroxine (fT4) values) to 94.6% (prolactin values)

Reduced Acquisition Time [18F]GE-180 PET Scanning Protocol Replaces Gold-Standard Dynamic Acquisition in a Mouse Ischemic Stroke Model

Aim Understanding neuroinflammation after acute ischemic stroke is a crucial step on the way to an individualized post-stroke treatment. Microglia activation, an essential part of neuroinflammation, can be assessed using [ 18 F]GE-180 18 kDa translocator protein positron emission tomography (TSPO-PET). However, the commonly used 60–90 min post-injection (p.i.) time window was not yet proven to be suitable for post-stroke neuroinflammation assessment. In this study, we compare semi-quantitative estimates derived from late time frames to quantitative estimates calculated using a full 0–90 min dynamic scan in a mouse photothrombotic stroke (PT) model. Materials and Methods Six mice after PT and six sham mice were included in the study. For a half of the mice, we acquired four serial 0–90 min scans per mouse (analysis cohort) and calculated standardized uptake value ratios (SUVRs; cerebellar reference) for the PT volume of interest (VOI) in five late 10 min time frames as well as distribution volume ratios (DVRs) for the same VOI. We compared late static 10 min SUVRs and the 60–90 min time frame of the analysis cohort to the corresponding DVRs by linear fitting. The other half of the animals received a static 60–90 min scan and was used as a validation cohort. We extrapolated DVRs by using the static 60–90 min p.i. time window, which were compared to the DVRs of the analysis cohort. Results We found high linear correlations between SUVRs and DVRs in the analysis cohort for all studied 10 min time frames, while the fits of the 60–70, 70–80, and 80–90 min p.i. time frames were the ones closest to the line of identity. For the 60–90 min time window, we observed an excellent linear correlation between SUVR and DVR regardless of the phenotype (PT vs . sham). The extrapolated DVRs of the validation cohort were not significantly different from the DVRs of the analysis group. Conclusion Simplified quantification by a reference tissue ratio of the late 60–90 min p.i. [ 18 F]GE-180 PET image can replace full quantification of a dynamic scan for assessment of microglial activation in the mouse PT model

GAD antibody-associated limbic encephalitis in a young woman with APECED

The autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED) syndrome is a genetic disorder caused by a mutation in the autoimmune regulator (AIRE) gene. Immune deficiency, hypoparathyroidism and Addison’s disease due to autoimmune dysfunction are the major clinical signs of APECED. We report on a 21-year-old female APECED patient with two inactivating mutations in the AIRE gene. She presented with sudden onset of periodic nausea. Adrenal insufficiency was diagnosed by means of the ACTH stimulation test. Despite initiation of hormone replacement therapy with hydrocortisone and fludrocortisone, nausea persisted and the patient developed cognitive deficits and a loss of interest which led to the diagnosis of depression. She was admitted to the psychiatric department for further diagnostic assessment. An EEG showed a focal epileptic pattern. Glutamic acid decarboxylase (GAD) antibodies, which had been negative eight years earlier, were now elevated in serum and in the cerebrospinal fluid. Oligoclonal bands were positive indicating an inflammatory process with intrathecal antibody production in the central nervous system (CNS). The periodic nausea was identified as dialeptic seizures, which clinically presented as gastrointestinal aura followed by episodes of reduced consciousness that occurred about 3–4 times per day. GAD antibody-associated limbic encephalitis (LE) was diagnosed. Besides antiepileptic therapy, an immunosuppressive treatment with corticosteroids was initiated followed by azathioprine. The presence of nausea and vomiting in endocrine patients with autoimmune disorders is indicative of adrenal insufficiency. However, our case report shows that episodic nausea may be a symptom of epileptic seizures due to GAD antibodies-associated LE in patients with APECED

Acceptability of yogurt and yogurt-like products: influenceof product information and consumer characteristics and preferences

19 pages, 8 tables, 3 figures.-- Printed version published in July 2010.-- The definitive version is available at www3.interscience.wiley.comThis work aims to investigate whether the information about product type and the nutritional label affects consumer acceptability of yogurt and fermented milk. Hedonic evaluations of seven commercial samples, three yogurts and four fermented milks were elicited from 120 consumers under blind tasting conditions, looking at a card with the product type and with the label nutritional facts and finally, tasting labeled products. For the whole group of consumers, nutritional information did not affect the acceptability of these products although analysis of individual consumer behavior showed that only for around 50% of consumers surveyed, this result reflects on their actual response. When data for subgroups of consumers of different gender or age or with different preference pattern were considered, differences in the influence of nutritional information on samples acceptability were detected. These results confirm that the data averaged from the consumer whole population cannot accurately reflect the real behavior of the population surveyed. More complete and valid information can be gained from analyzing the responses of the consumer subgroups of different characteristics or with different individual preferences.To MICINN of Spain for financial support (Project AGL 2007-63444). To Fondo Social Europeo for financing the contract of author S. Bayarri in the program I3P from CSICPeer reviewe

CADASIL Affects Multiple Aspects of Cerebral Small Vessel Function on 7T-MRI

International audienceObjective: Cerebral small vessel diseases (cSVDs) are a major cause of stroke and dementia. We used cutting-edge 7T-MRI techniques in patients with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), to establish which aspects of cerebral small vessel function are affected by this monogenic form of cSVD. Methods: We recruited 23 CADASIL patients (age 51.1 AE 10.1 years, 52% women) and 13 age-and sex-matched controls (46.1 AE 12.6, 46% women). Small vessel function measures included: basal ganglia and centrum semiovale perforating artery blood flow velocity and pulsatility, vascular reactivity to a visual stimulus in the occipital cortex and reactivity to hypercapnia in the cortex, subcortical gray matter, white matter, and white matter hyperintensities. Results: Compared with controls, CADASIL patients showed lower blood flow velocity and higher pulsatility index within perforating arteries of the centrum semiovale (mean difference À 0.09 cm/s, p = 0.03 and 0.20, p = 0.009) and basal ganglia (mean difference À 0.98 cm/s, p = 0.003 and 0.17, p = 0.06). Small vessel reactivity to a short visual stimulus was decreased (blood-oxygen-level dependent [BOLD] mean difference À0.21%, p = 0.04) in patients, while reactivity to hypercapnia was preserved in the cortex, subcortical gray matter, and normal appearing white matter. Among patients, reactivity to hypercapnia was decreased in white matter hyperintensities compared to normal appearing white matter (BOLD mean difference À0.29%, p = 0.02). Interpretation: Multiple aspects of cerebral small vessel function on 7T-MRI were abnormal in CADASIL patients, indicative of increased arteriolar stiffness and regional abnormalities in reactivity, locally also in relation to white matter injury. These observations provide novel markers of cSVD for mechanistic and intervention studies